Journal
CANCER
Volume 120, Issue 20, Pages 3111-3121Publisher
WILEY
DOI: 10.1002/cncr.28743
Keywords
hepatic metastases; noncolorectal; neuroendocrine; melanoma; breast cancer; renal cell carcinoma; sarcoma
Categories
Funding
- NCI NIH HHS [T32 CA126607] Funding Source: Medline
Ask authors/readers for more resources
The number of hepatectomies performed for metastatic cancer has dramatically increased over the past 2 decades. Hepatectomy for stage IV colorectal cancer is now considered the standard of care for resectable patients with isolated hepatic disease and acceptable performance status. However, the indications for resection of noncolorectal origin liver metastases are not as clearly defined. This review focuses on emerging data for the resection of noncolorectal metastatic disease to the liver, with a focus on indications for surgical resection. Specifically, we review the current data on the surgical management of nonneuroendocrine and neuroendocrine tumors metastatic to the liver. (C) 2014 American Cancer Society.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available